Beyond Air (XAIR) Fundamentals 2026 — Revenue Analysis | SniperIQ
Beyond Air (XAIR) is a US-listed Healthcare company in Medical - Devices with a market capitalization of $4M, trading at $5.61 on the NASDAQ. This SniperIQ fundamentals page covers Beyond Air's valuation, profitability (net margin -433.0%), revenue ($8M in FY2026), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Beyond Air's market cap?
Beyond Air (XAIR) has a market capitalization of approximately $4M, trading at $5.61 on the NASDAQ. Market cap moves with the live share price.
What is Beyond Air's P/E ratio?
Beyond Air's trailing twelve-month P/E ratio is not meaningful (negative or nil earnings), with a price-to-book (P/B) of 0.4x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is Beyond Air?
Beyond Air runs a net profit margin of -433.0%, a gross margin of 3.3%, and an operating margin of -378.2%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Beyond Air generate?
Beyond Air reported revenue of $8M for fiscal year 2026, with net income of -